Biocidal products must be authorised prior to being placed on the market in an EU Member State. In order to obtain this authorisation, a dossier must be submitted meeting the data requirements set by the Regulation, and including information on: the physical and technical properties of the product; the effectiveness against target organisms and impact on non-target organisms; the intented uses and exposure; the toxicological and ecotoxicological effects; and the environmental fate. There is also a significant cost involved. Authorisations, when granted, may apply to an individual Member State or Union-wide.
One key requirement of an authorisation being granted is that the active substance(s) it contains have been approved for use in the product-type into which the biocidal product falls. This approval is undertaken at Union level and a list of those substances approved and the product-type(s) in which they may be incorporated is published on the website of the European Chemicals Agency (ECHA).
At present the processing of applications for approval of active substances is following a 10-year review programme so not all active substances have been assessed. This means it may be possible to continue placing your biocidal product on the market without an authorisation until the active substance(s) within it are approved.
Top